Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,154 | -88,853 | -70,242 | -51,222 | -15,579 |
| Depreciation Amortization | -983 | -352 | 190 | 198 | 105 |
| Accounts payable and accrued liabilities | 1,064 | -1,217 | -1,389 | -1,163 | -2,895 |
| Other Working Capital | 94,152 | 89,288 | 10,713 | 4,911 | -1,179 |
| Other Operating Activity | 4,208 | 19,432 | 17,386 | 15,003 | 3,097 |
| Operating Cash Flow | $72,287 | $18,298 | $-43,342 | $-32,273 | $-16,451 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,280 | -359 | -245 | -173 | -134 |
| Purchase Of Investment | -49,451 | -283,372 | -138,699 | -29,790 | -29,790 |
| Sale Of Investment | 88,000 | 81,000 | 50,000 | 35,000 | 20,000 |
| Investing Cash Flow | $36,269 | $-202,731 | $-88,944 | $5,037 | $-9,924 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 196 | 170,621 | 109,931 | 908 | 667 |
| Common Stock Repurchased | -50 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -738 | -35 | -35 | -35 |
| Financing Cash Flow | $146 | $169,883 | $109,896 | $873 | $632 |
| Beginning Cash Position | 54,983 | 69,533 | 69,533 | 69,533 | 69,533 |
| End Cash Position | 163,685 | 54,983 | 47,143 | 43,170 | 43,790 |
| Net Cash Flow | $108,702 | $-14,550 | $-22,390 | $-26,363 | $-25,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | 72,287 | 18,298 | -43,342 | -32,273 | -16,451 |
| Capital Expenditure | -2,280 | -359 | -245 | -173 | -134 |
| Free Cash Flow | 70,007 | 17,939 | -43,587 | -32,446 | -16,585 |